195 related articles for article (PubMed ID: 16611940)
21. SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain.
Tange TØ; Kjems J
J Mol Biol; 2001 Sep; 312(4):649-62. PubMed ID: 11575921
[TBL] [Abstract][Full Text] [Related]
22. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities.
Tacke R; Manley JL
EMBO J; 1995 Jul; 14(14):3540-51. PubMed ID: 7543047
[TBL] [Abstract][Full Text] [Related]
23. The human splicing factor ASF/SF2 can specifically recognize pre-mRNA 5' splice sites.
Zuo P; Manley JL
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3363-7. PubMed ID: 7512732
[TBL] [Abstract][Full Text] [Related]
24. The essential pre-mRNA splicing factor SF2 influences 5' splice site selection by activating proximal sites.
Krainer AR; Conway GC; Kozak D
Cell; 1990 Jul; 62(1):35-42. PubMed ID: 2364434
[TBL] [Abstract][Full Text] [Related]
25. Roles for SR proteins and hnRNP A1 in the regulation of c-src exon N1.
Rooke N; Markovtsov V; Cagavi E; Black DL
Mol Cell Biol; 2003 Mar; 23(6):1874-84. PubMed ID: 12612063
[TBL] [Abstract][Full Text] [Related]
26. Coupled transcription-splicing regulation of mutually exclusive splicing events at the 5' exons of protein 4.1R gene.
Huang SC; Cho A; Norton S; Liu ES; Park J; Zhou A; Munagala ID; Ou AC; Yang G; Wickrema A; Tang TK; Benz EJ
Blood; 2009 Nov; 114(19):4233-42. PubMed ID: 19729518
[TBL] [Abstract][Full Text] [Related]
27. PLP1 alternative splicing in differentiating oligodendrocytes: characterization of an exonic splicing enhancer.
Wang E; Huang Z; Hobson GM; Dimova N; Sperle K; McCullough A; Cambi F
J Cell Biochem; 2006 Apr; 97(5):999-1016. PubMed ID: 16288477
[TBL] [Abstract][Full Text] [Related]
28. The deep intronic c.903+469T>C mutation in the MTRR gene creates an SF2/ASF binding exonic splicing enhancer, which leads to pseudoexon activation and causes the cblE type of homocystinuria.
Homolova K; Zavadakova P; Doktor TK; Schroeder LD; Kozich V; Andresen BS
Hum Mutat; 2010 Apr; 31(4):437-44. PubMed ID: 20120036
[TBL] [Abstract][Full Text] [Related]
29. An intron enhancer recognized by splicing factors activates polyadenylation.
Lou H; Gagel RF; Berget SM
Genes Dev; 1996 Jan; 10(2):208-19. PubMed ID: 8566754
[TBL] [Abstract][Full Text] [Related]
30. A Novel Mutation in the Fibrinogen Bβ Chain (c.490G>A; End of Exon 3) Causes a Splicing Abnormality and Ultimately Leads to Congenital Hypofibrinogenemia.
Taira C; Matsuda K; Arai S; Sugano M; Uehara T; Okumura N
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156616
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways.
Wang J; Manley JL
RNA; 1995 May; 1(3):335-46. PubMed ID: 7489505
[TBL] [Abstract][Full Text] [Related]
32. An exonic splicing enhancer offsets the atypical GU-rich 3' splice site of human apolipoprotein A-II exon 3.
Arrisi-Mercado P; Romano M; Muro AF; Baralle FE
J Biol Chem; 2004 Sep; 279(38):39331-9. PubMed ID: 15247216
[TBL] [Abstract][Full Text] [Related]
33. Human splicing factor ASF/SF2 encodes for a repressor domain required for its inhibitory activity on pre-mRNA splicing.
Dauksaite V; Akusjärvi G
J Biol Chem; 2002 Apr; 277(15):12579-86. PubMed ID: 11801589
[TBL] [Abstract][Full Text] [Related]
34. SRp30c is a repressor of 3' splice site utilization.
Simard MJ; Chabot B
Mol Cell Biol; 2002 Jun; 22(12):4001-10. PubMed ID: 12024014
[TBL] [Abstract][Full Text] [Related]
35. Pre-mRNA splicing in the absence of an SR protein RS domain.
Zhu J; Krainer AR
Genes Dev; 2000 Dec; 14(24):3166-78. PubMed ID: 11124808
[TBL] [Abstract][Full Text] [Related]
36. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins.
Zhu J; Mayeda A; Krainer AR
Mol Cell; 2001 Dec; 8(6):1351-61. PubMed ID: 11779509
[TBL] [Abstract][Full Text] [Related]
37. HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cells.
Guo R; Li Y; Ning J; Sun D; Lin L; Liu X
PLoS One; 2013; 8(4):e62729. PubMed ID: 23658645
[TBL] [Abstract][Full Text] [Related]
38. A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression.
Caputi M; Freund M; Kammler S; Asang C; Schaal H
J Virol; 2004 Jun; 78(12):6517-26. PubMed ID: 15163745
[TBL] [Abstract][Full Text] [Related]
39. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
[TBL] [Abstract][Full Text] [Related]
40. Functional domains of the human splicing factor ASF/SF2.
Zuo P; Manley JL
EMBO J; 1993 Dec; 12(12):4727-37. PubMed ID: 8223481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
